Manipal Health Enterprises (NSE:MANIPALHOS) ROCE %: 10.51% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MANIPALHOS Manipal Health Enterprises Ltd NSE:MANIPALHOS
13 GF Score
Price ₹771.65
! 1 Warning Sign
View Full Analysis

What is Manipal Health Enterprises ROCE %?

Manipal Health Enterprises NSE:MANIPALHOS -3.30% 13 ROCE % is 10.51% as of Mar. 2026. GuruFocus rates NSE:MANIPALHOS with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Manipal Health Enterprises's annualized ROCE % for the quarter that ended in Mar. 2026 was 10.51%.

Manipal Health Enterprises  (NSE:MANIPALHOS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Manipal Health Enterprises ROCE % Related Terms

Manipal Health Enterprises ROCE % Historical Data

* Premium members only.

The historical data trend for Manipal Health Enterprises's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Manipal Health Enterprises ROCE % Chart

Manipal Health Enterprises Annual Data
Trend Mar24 Mar25 Mar26
ROCE %
12.55 13.44 10.51

Manipal Health Enterprises Semi-Annual Data
Mar24 Mar25 Mar26
ROCE % 12.55 13.44 10.51
NSE:MANIPALHOS
13GF Score
Manipal Health Enterprises Ltd NSE:MANIPALHOS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Manipal Health Enterprises ROCE % Calculation

Manipal Health Enterprises's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=21140.71/( ( (214438.1 - 27345.44) + (248645.03 - 33623.72) )/ 2 )
=21140.71/( (187092.66+215021.31)/ 2 )
=21140.71/201056.985
=10.51 %

Manipal Health Enterprises's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=21140.71/( ( (214438.1 - 27345.44) + (248645.03 - 33623.72) )/ 2 )
=21140.71/( ( 187092.66 + 215021.31 )/ 2 )
=21140.71/201056.985
=10.51 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 10.51% mean?
Manipal Health Enterprises (NSE:MANIPALHOS) has a ROCE % of 10.51% as of Mar. 2026.
Is Manipal Health Enterprises' ROCE % too high?
Manipal Health Enterprises' current ROCE % is 10.51%. The Healthcare Providers & Services industry median ROCE % is 6.58. Manipal Health Enterprises' value of 10.51% is 59.7% above this industry median. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' ROCE % compare to ?
Manipal Health Enterprises' ROCE % of 10.51% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.58. Manipal Health Enterprises' value of 10.51% is 59.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.58, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Manipal Health Enterprises's current ROCE % of 10.51% is 59.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Manipal Health Enterprises's current ROCE % is 10.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (NSE:MANIPALHOS) has a current ROCE % of 10.51%. The current ROCE % is 10.51% and 59.7% above the Healthcare Providers & Services industry median of 6.58. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Manipal Health Enterprises (NSE:MANIPALHOS), the current ROCE % is 10.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Manipal Health Enterprises Business Description

Comparable Companies
Other Exchanges 544847:India
Address HAL Airport Road, Rustom Bagh road, The Annexe, no. 98/2, Bengaluru, KA, IND, 560 017
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score

Get the complete analysis for NSE:MANIPALHOS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹771.65
Price